The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes

- Quinlivan, A., Neuen, D., Apostolopoulos, D., Host, L. V., Major, G., Basnayake, C., Morrisroe, K., Nikpour, M., Hansen, D., Stevens, W., Ross, L., Ferdowsi, N., Proudman, S. M., Walker, J. G., Sahhar, J., Ngian, G-S.

Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features: Further Lessons from COLDICE, a Prospective Multicenter Clinical Trial

- Cooper, Wendy A., Mahar, Annabelle, Myers, Jeffrey L., Grainge, Christopher, Corte, Tamera J., Williamson, Jonathan P., Vallely, Michael P., Lai, Simon, Mulyadi, Ellie, Torzillo, Paul J., Phillips, Martin J., Lau, Edmund M. T., Raghu, Ganesh, Troy, Lauren K.

Annexin A2 contributes to lung injury and fibrosis by augmenting factor Xa fibrogenic activity

- Schuliga, Michael, Jaffar, Jade, Stewart, Alastair G., Berhan, Asres, Langenbach, Shenna, Harris, Trudi, Waters, David, Lee, Peter V. S., Grainge, Christopher, Westall, Glen, Knight, Darryl

Australian and New Zealand Pulmonary Rehabilitation Guidelines

- Alison, Jennifer A., McKeough, Zoe J., Brooke, Michelle, Cameron-Tucker, Helen L., Candy, Sarah, Cecins, Nola, Chan, Andrew S. L., Dale, Marita T., Dowman, Leona M., Granger, Catherine, Halloran, Simon, Jung, Peter, Johnston, Kylie, McNamara, Renae J., Spencer, Lissa M., Jenkins, Sue C., Hill, Catherine J., McDonald, Vanessa M., Frith, Peter, Cafarella, Paul

Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

- Jo, Helen E., Troy, Lauren K., Whitford, Helen, Chapman, Sally, Reynolds, Paul N., Glaspole, Ian, Beatson, David, Jones, Leonie, Hopkins, Peter, Corte, Tamera J., Keir, Gregory, Chambers, Daniel C., Holland, Anne, Goh, Nicole, Wilsher, Margaret, de Boer, Sally, Moodley, Yuben, Grainge, Christopher